Rab25 as a tumour suppressor in colon carcinogenesis

J. R. Goldenring, KiTaek Nam

Research output: Contribution to journalReview article

53 Citations (Scopus)

Abstract

Recent investigations have increasingly focussed attention on the roles of intracellular vesicle trafficking in the regulation of epithelial polarity and transformation. Rab25, an epithelial-specific member of the Rab family of small GTPases, has been associated with several epithelial cancers. Whereas Rab25 overexpression is associated with ovarian cancer aggressive behaviour, Rab25 expression is decreased in human colon cancers independent of stage. Recent studies of mouse models of intestinal and colonic neoplasia have demonstrated that Rab25 deficiency markedly promotes the development of neoplasia. Some of these effects appear related to alterations in Β1-integrin trafficking to the cell surface. These findings all suggest that Rab25 is a tumour suppressor for colonic neoplasia.

Original languageEnglish
Pages (from-to)33-36
Number of pages4
JournalBritish Journal of Cancer
Volume104
Issue number1
DOIs
Publication statusPublished - 2011 Jan 4

Fingerprint

Colon
Carcinogenesis
Neoplasms
Monomeric GTP-Binding Proteins
Integrins
Ovarian Neoplasms
Colonic Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Goldenring, J. R. ; Nam, KiTaek. / Rab25 as a tumour suppressor in colon carcinogenesis. In: British Journal of Cancer. 2011 ; Vol. 104, No. 1. pp. 33-36.
@article{f6134037e2c5431e9bf7f15979ae0224,
title = "Rab25 as a tumour suppressor in colon carcinogenesis",
abstract = "Recent investigations have increasingly focussed attention on the roles of intracellular vesicle trafficking in the regulation of epithelial polarity and transformation. Rab25, an epithelial-specific member of the Rab family of small GTPases, has been associated with several epithelial cancers. Whereas Rab25 overexpression is associated with ovarian cancer aggressive behaviour, Rab25 expression is decreased in human colon cancers independent of stage. Recent studies of mouse models of intestinal and colonic neoplasia have demonstrated that Rab25 deficiency markedly promotes the development of neoplasia. Some of these effects appear related to alterations in Β1-integrin trafficking to the cell surface. These findings all suggest that Rab25 is a tumour suppressor for colonic neoplasia.",
author = "Goldenring, {J. R.} and KiTaek Nam",
year = "2011",
month = "1",
day = "4",
doi = "10.1038/sj.bjc.6605983",
language = "English",
volume = "104",
pages = "33--36",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "1",

}

Rab25 as a tumour suppressor in colon carcinogenesis. / Goldenring, J. R.; Nam, KiTaek.

In: British Journal of Cancer, Vol. 104, No. 1, 04.01.2011, p. 33-36.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Rab25 as a tumour suppressor in colon carcinogenesis

AU - Goldenring, J. R.

AU - Nam, KiTaek

PY - 2011/1/4

Y1 - 2011/1/4

N2 - Recent investigations have increasingly focussed attention on the roles of intracellular vesicle trafficking in the regulation of epithelial polarity and transformation. Rab25, an epithelial-specific member of the Rab family of small GTPases, has been associated with several epithelial cancers. Whereas Rab25 overexpression is associated with ovarian cancer aggressive behaviour, Rab25 expression is decreased in human colon cancers independent of stage. Recent studies of mouse models of intestinal and colonic neoplasia have demonstrated that Rab25 deficiency markedly promotes the development of neoplasia. Some of these effects appear related to alterations in Β1-integrin trafficking to the cell surface. These findings all suggest that Rab25 is a tumour suppressor for colonic neoplasia.

AB - Recent investigations have increasingly focussed attention on the roles of intracellular vesicle trafficking in the regulation of epithelial polarity and transformation. Rab25, an epithelial-specific member of the Rab family of small GTPases, has been associated with several epithelial cancers. Whereas Rab25 overexpression is associated with ovarian cancer aggressive behaviour, Rab25 expression is decreased in human colon cancers independent of stage. Recent studies of mouse models of intestinal and colonic neoplasia have demonstrated that Rab25 deficiency markedly promotes the development of neoplasia. Some of these effects appear related to alterations in Β1-integrin trafficking to the cell surface. These findings all suggest that Rab25 is a tumour suppressor for colonic neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=78650886573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650886573&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6605983

DO - 10.1038/sj.bjc.6605983

M3 - Review article

VL - 104

SP - 33

EP - 36

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 1

ER -